Tenderwize
Wróć do wyszukiwania

Open-house rebate contracts for risperidone parenteral depot products

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Risperidon, als parenterale Depotform, ATC N05AX08

46/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

46 / 100

Złożoność

58 / 100

Czynniki ryzyka

Submission must be in original paper form and electronic submission is not allowed, creating courier and timing risk.

If the product is not already listed in Lauer-Taxe, the bidder must provide AMIce evidence and possibly supplementary p...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive open-house rebate contracts for pharmaceutical products containing risperidone in parenteral depot form.
  • Uniform contract conditions for all participating pharmaceutical companies; no individual negotiations.
Pokaż pełne podsumowanie

Open-house supply arrangement for non-exclusive pharmaceutical rebate contracts for risperidone in parenteral depot form (ATC N05AX08) offered by AOK Rheinland-Pfalz/Saarland. The notice states that this is not a public contract award in the usual procurement sense, but a transparency publication for contract access. One lot is present. Contracting is open to interested pharmaceutical companies on uniform terms, with no individual negotiations. The earliest contract start is 2025-06-01 and the maximum term is 24 months. Submission is by original paper documents; electronic submission is not allowed. Procurement documents are available via the notice link, but no extracted contract documents were provided for analysis.

Ryzyka

Submission must be in original paper form and electronic submission is not allowed, creating courier and timing risk.

If the product is not already listed in Lauer-Taxe, the bidder must provide AMIce evidence and possibly supplementary p...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Only approved and marketable medicines in Germany may be supplied under the contract.
  • If the product is already listed in Lauer-Taxe as marketable, this is deemed proven.

Administrative

  • If not yet listed in Lauer-Taxe at submission time, the contractor must provide an extract from the public AMIce database and, where needed, supplementary evidence such as...

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open-house rebate contracts for risperidone parenteral depot products

Non-exclusive open-house rebate contracts for medicinal products containing risperidone in parenteral depot form (ATC N05AX08). The scope is limited to the named active substance/form. The notice excludes medicines listed as children's medicines under the BfArM list pursuant to Section 35(5a) SGB V. Contract terms are uniform for all participants and no individual negotiation is foreseen. Contracts may start on the first day of a month within the 24-month period, with the earliest start on 2025-06-01 and final end no later than 24 months after that date. The lot is based on structured notice data and XML notice text.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

May 2025 - May 2027

Kategoria

Pharmaceutical products

Termin

Deadline Mar 31, 2027

Szczegóły zamówienia

Data publikacji
10 Apr 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
237162-2025

Dokumenty (1)

Podobne przetargi